Federal Paperwork Law Poses Obstacle To Valid Research

WASHINGTON—In 1985 the National Institute of Occupational Safety and Health decided to find out if computer monitors cause miscarriages. So it did what any good research body would do: It drew up a questionnaire to ask women about their medical history, work and home life, and fertility. But because NIOSH is a federal agency, the survey first had to pass muster at the Office of Management and Budget (0MB). 0MB rejected it, carrying out its authority under a 1980 law, meant to reduce

| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

WASHINGTON—In 1985 the National Institute of Occupational Safety and Health decided to find out if computer monitors cause miscarriages. So it did what any good research body would do: It drew up a questionnaire to ask women about their medical history, work and home life, and fertility. But because NIOSH is a federal agency, the survey first had to pass muster at the Office of Management and Budget (0MB).

0MB rejected it, carrying out its authority under a 1980 law, meant to reduce the burden on citizens from government paperwork. According to two separate reports, that decision is an example of the heavy hand that 0MB has wielded in monitoring the activities of federal research agencies. 0MB too often acts out of ignorance or ideological bias, say the reports, rather than following the law’s intent to reduce the amount of paperwork generated by the federal government.

The new reports, from ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • Christopher Anderson

    This person does not yet have a bio.

Published In

Share
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

sartorius logo
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo

Products

Photo of a researcher overseeing large scale production processes in a laboratory.

Scaling Lentiviral Vector Manufacturing for Optimal Productivity

Thermo Fisher Logo
Collage-style urban graphic of wastewater surveillance and treatment

Putting Pathogens to the Test with Wastewater Surveillance

An illustration of an mRNA molecule in front of a multicolored background.

Generating High-Quality mRNA for In Vivo Delivery with lipid nanoparticles

Thermo Fisher Logo
Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide